Leveraging deep learning and structure-based drug repurposing for the discovery of potent Trk-A inhibitors targeting CIPA
Bioorganic Chemistry · 2025
DOI: 10.1016/j.bioorg.2025.108680 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioorganic Chemistry, 2025. Verfasst von Muhammad Waleed Iqbal und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Chemical Resources Engineering, Beijing University of Chemical Technology, Beijing 100029, PR China. Hauptthemen laut MEDLINE: Drug Repositioning, Deep Learning, Protein Kinase Inhibitors, Receptor, trkA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Key Technologies Research and Development Program, King Saud University, Beijing University of Chemical Technology.
Abstract (Originalsprache)
Nerve growth factor receptor Trk-A is essential for neurons' survival, growth, and function. The mutations in its gene can cause a disorder called CIPA, which requires the inhibition of Trk-A for preventing CIPA. Reported inhibitors of Trk-A exhibited challenges related to specificity and selectivity. This study used an integrated deep learning and structure-based drug repurposing approach to identify novel, potent, and non-toxic Trk-A inhibitors. Deep learning-based artificial neural network (ANN) models were trained and tested based on Trk-A targeting compounds' already existing bioactivity data. The trained ANN models were assessed for their performance, and a reliable model was employed to screen highly potent compounds from the FDA-approved drugs library. The screened drugs were further evaluated using molecular docking and identified gonadoliberin, caerulein, anidulafungin, and micafungin as potential Trk-A inhibitors. Molecular simulation analysis, including RMSD, RMSF, Rg, H-bonds, PCA, and MMGBSA/MMPBSA, further confirmed the stability of the selected drugs with Trk-A.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Chemical Resources Engineering, Beijing University of Chemical Technology, Beijing 100029, PR China.
- International Joint Laboratory on Synthetic Biology and Biomass Biorefinery, Biofuels Institute, School of Emergency Management, School of the Environment and Safety Engineering, Jiangsu University, Zhenjiang 212013, Ch…
- Department of Zoology, College of Science, King Saud University, Riyadh 11451, Saudi Arabia.
- State Key Laboratory of Chemical Resources Engineering, Beijing University of Chemical Technology, Beijing 100029, PR China. Electronic address: yuanqp@mail.buct.edu.cn.
Förderung
- Key Technologies Research and Development Program
- King Saud University
- Beijing University of Chemical Technology
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- State Key Laboratory of Chemical Resource Engineering
Zitieren
APA
Iqbal, M. W., Haider, S. Z., Sun, X., Al-Ghanim, K. A., Nawaz, M. Z., & Yuan, Q. (2025). Leveraging deep learning and structure-based drug repurposing for the discovery of potent Trk-A inhibitors targeting CIPA. Bioorganic Chemistry. https://doi.org/10.1016/j.bioorg.2025.108680
Vancouver
Iqbal MW, Haider SZ, Sun X, Al-Ghanim KA, Nawaz MZ, Yuan Q. Leveraging deep learning and structure-based drug repurposing for the discovery of potent Trk-A inhibitors targeting CIPA. Bioorganic Chemistry. 2025. doi:10.1016/j.bioorg.2025.108680
BibTeX
@article{Iqbal2025,
author = {Iqbal, Muhammad Waleed and Haider, Syed Zeeshan and Sun, Xinxiao and Al-Ghanim, Khalid A and Nawaz, Muhammad Zohaib and Yuan, Qipeng},
title = {Leveraging deep learning and structure-based drug repurposing for the discovery of potent Trk-A inhibitors targeting CIPA},
journal = {Bioorganic Chemistry},
year = {2025},
doi = {10.1016/j.bioorg.2025.108680}
}
EUVIMED